Abstract
During the last two decades the different roles of central neurotransmitters in controlling mental functions have been key issues in neuroscience. The identification of acetylcholine (ACh) in brain tissue by Stedman and Sted-man (81) 40 years ago and the finding of Richter and Crossland (70) that the level of brain ACh varies inversely with the state of consciousness in experimental animals became two milestones in elucidating the central effects of this transmitter. During the last few years there has been a rapidly growing interest in applying to clinical practice the now large body of animal data. In this overview our current knowledge, with respect to clinical manifestations of cholinergic dysfunctions will be presented. Some techniques, which have been used as diagnostic tools in this context and as pharmacological means to treat these dysfunctions, will also be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aquilonius, S.-M., Eckernas, S.-Å. and Sundwall, A.J. (1975): J. Neurol. Neurosurg. Psychiat. 38:669–677.
Aquilonius, S.-M., Ceder, G., Lying-Tunell, U., Malmlund, H.O. and Schuberth, J. (1975): Brain Res. 99:430–433.
Aquilonius, S.-M., Nystrom, B., Schuberth, J. and Sundwall, A. (1972): J. Neurol. Neurosurg. Psychiat. 25:720–725.
Aquilonius, S.-M., Schuberth, J. and Sundwall, A. (1970): In: Drugs and Cholinergic Mechanisms in the CNS: Choline in the Cerebrospinal Fluid as a Marker for the Release of Acetylcholine, (Eds.) E. Heilbronn and A. Winter, Research Institute of National Defence, Stockholm.
Aquilonius, S.-M. and Sjöström, R. (1971): Life Sci. 10:405–414.
Beaton, J.M., Smythies, J.R. and Bradley, R.J. (1975): Biol. Psychiat. 10:45–52.
Bernards, W. (1973): Anesthetic Analgetics (Cleveland) 52:938–941.
Bockenheimer, S. and Lucius, G. (1976): Arch. Psychiat. Nervenkr. 222:69–75.
Bovet, D., Leathwood, P., Mauron, J., Oliviero, A. and Satta, M. (1971): Psychopharmacology 22:91–99.
Carlsson, A. (1970): In: L-DOPA and Parkinsonism: Biochemical Implications of DOPA-induced Actions on the Central Nervous System, with Particular Reference to Abnormal Movements, (Eds.) A. Barbeau and F. H. McDowell, Davis, Philadelphia.
Ceder, G. and Schuberth, J. (1977): in preparation.
Ceder, G. and Schuberth, J. (1977): J. Pharm. Pharmacol., in press.
Ceder, G. and Schuberth, J. (1977): Brain Res., in press.
Choi, R. L., Freeman, J.J. and Jenden, D.J. (1975): J. Neurochem. 24:735–741.
Christison, R. (1855): Monthly J. Med. (Lond.) 20:193–204.
Cohen, E.L. and Wurtman, R.J. (1975): Life Sci. 16:1095–1102.
Cohen, E.L. and Wurtman, R.J. (1976): Science 191:561–562.
Dahlberg, L. and Schuberth, J. (1977): in preparation.
Dahlberg, L. and Schuberth, J. (1977): in preparation.
Daniel, R.G. and Waisman, H.A. (1969): J. Neurochem. 16:787–795.
Danysz, A., Kocmierske-Grodzka, D., Kostro, B., Polocki, B. and Kruszewska, J. (1967): Diss. Pharm. Pharmacol. 19:469–477.
Davis, K. L., Hollister, L. E., Barchas, J. D. and Berger, P.A. (1976): Life Sci. 19:1507–1516.
Drachman, D.A. and Leavitt, J. (1974): Arch. Neurol. 30:113–121.
Duvoisin, R. C. (1967): Arch. Neurol. 17:124–136.
El-Yousef, M.K., Janowsky, D.S., Davis, J.M. and Rosenblatt, J. E. (1975): Brit. J. Addict. 68:321–325.
Fann, W.E. and Lake, C.R. (1974): Dis. Nerv. Syst. 35:324–326.
Fann, W. E., Sullivan, J. L., Miller, R.D. and McKenzie, G. M. (1975): Psychopharmacology 42:135–137.
Floyd, J. C., Fajans, S.S., Conn, J.W., Knopf, R.F. and Rull, J. (1966): J. Clin, Invest. 45:1487–1502.
Freeman, J. J., Choi, R. L. and Jenden, D.J. (1975): J. Neurochem. 24:729–734.
Freeman, F.R., Rosenblatt, J. E. and El-Yousef, M.K. (1975): Clin. Pharmacol. Ther. 17:121–126.
Gerlach, J., Reisby, N. and Randrup, A. (1974): Psychopharmacology 34:21–35.
Gershon, S. and Shaw, F.H. (1961): Lancet 1:1371–1374.
Goldner, R. (1967): Int. J. Neuropsychiat. 3:234.
Granacher, R.P. and Baldessarini, R.J. (1976): In: Clinical Neuropharmacology Vol. 1: The Usefulness of Physostigmine in Neurology and Psychiatry. (Ed.) H.L. Klawans, Raven Press, New York.
Grob, D. and Harvey, J. C. (1958): J. Clin. Invest. 37:350–368.
Green, V.A. and Davis, J.E. (1956): Fed. Proc. 15:431.
Greig, M.E. and Mayberry, T.C. (1951): J. Pharmacol. Exp. Ther. 102:1–4.
Grundig, E. and Gerstenbrand, F. (1970): Wein. Klin. Wschr. 82: 811–816.
Gründig, E. and Hanbauer, I. (1970): J. Neurochem. 17:215–220.
Grundig, E., Raheem, K.A., Salvenmoser, F., Schedl, R. and Weiss, J. (1976): Psyehopharmacology 47:111–118.
Hanin, I. and Schuberth, J. (1974): J. Neurochem. 23: 819–824.
Haubrieh, D.R., Wang, P.F.L., Clody, D.E. and Wedeking, P.W. (1975): Life Sci. 17:975–980.
Illingworth, D.R. and Portman, O.W. (1972): Biochem. J. 130:557–567.
Innés, J. R. and Nickerson, M. (1965): In: The Pharmacological Basis of Therapeutics, 3rd Ed. (Eds.) L.S. Goodman and A. Gilman, The Macmillan Company, New York, pp. 521–545.
Janowsky, D.S., El-Yousef, M.K. and Davis, J.M. (1974): Psychosom. Med. 36:248–257.
Janowsky, D.S., El-Yousef, M.K., Davis, J.M. and Sekerke, H.J. (1973): Amer. J. Psychiat. 130:1370–1376.
Janowsky, D.S., El-Yousef, M.K., Davis, J.M. and Sekerke, H.J. Arch. Gen. Psychiat. 28:542–547.
Jonsson, L. E., Schuberth, J. and Sundwall, A. (1969): Life Sci. 8:977–981.
Klawans, H. L. and Rubovits, R. (1974): J. Neurol. Neurosurg. Psychiat. 27:941–947.
Klawans, H. L. and Rubovits, R. (1972): Neurology 22:107–116.
Klawans, H. L., Topel, J. L. and Bergen, D. (1975): Neurology 25: 290–293.
Kostopoulos, G.K. and Phillis, J.W. (1975): Psychopharm. Commun. 2:339–347.
Lewis, J. A. and Young, R. (1975): Clin. Pharmacol. Ther. 17:534–540.
Longo, V.G. (1966): In: Pharmacological Reviews Vol. 18. (Ed.) G. H. Acheson, The Williams and Wilkins Co., Baltimore.
Malitz, S., Wilkens, B., Higgins, J. C. and Kanzler, M. (1967): Curr. Ther. Res. 9:261–264.
Matsuda, M., Meyer, J. S., Deshmukh, V.D. and Tagashira, Y. (1976): J. Neurosurg. 45:423–431.
McCance, I. (1964): Arch. Int. Pharmacodyn. 148:270–286.
McGeer, P.L. and McGeer, E.G. (1976): J. Neurochem. 26:65–76.
Miller, E. (1974): Neurology 24:116–119.
Miller, R.J. and Hiley, C.R. (1974): Nature (Lond.) 248:596–597.
Modestin, J., Hunger, J. and Schwartz, R. B. (1973): Arch. Psychiat. Nervenkr. 218:67–77.
Modestin, J., Schwartz, R.B. and Hunger, J. (1973): Pharmaco-psychiat. 9:300–304.
Murphree, H.B., Pfeiffer, C.C. and Backerman, I.A. (1960): Clin. Pharmacol. Ther. 1:303–310.
Oettinger, L. (1958): J. Pediat. 53:671–675.
Pepeu, G., Freedman, D.X. and Giarman, N.J. (1960): J. Pharmacol. Exp. Ther. 129:291–295.
Pfeiffer, C.C., Jenney, E.H., Gallagher, W., Smith, R.P., Bevan, W., Killam, K.F., Killam, E.K. and Blackmore, W. (1957): Science 126:610–611.
Pollin, W., Cardon, P. V. and Kety, S.S. (1961): Science 133:104–105.
Racagni, G., Cheney, D. L., Trabucchi, M. and Costa, E. (1976): J. Pharmacol. Exp. Ther. 196:323–332.
Racagni, G., Trabucchi, M. and Cheney, D. L. (1975): N.-S. Schmed. Arch. Pharmacol. 290:99–105.
Richter, D. and Crossland, J. (1949): Amer. J. Physiol. 159:247–255.
Safer, D.J. (1970): Clin. Pharmacol. Ther. 21:60–67.
Safer, D.J. (1970): Psychopharmacology 17:425–433.
Safer, D.J. and Allen, R.P. (1971): Biol. Psychiat. 3:347–355.
Sagaies, T., Brill, S. and Domino, E.F. (1967): Clin. Pharmacol. Ther. 10:523–529.
Satterfield, J. H. (1973): Semin. Psychiat. 5:35–46.
Schuberth, J. and Jenden, D.J. (1975): Brain Res. 84:245–256.
Schuberth, J., Sparf, B. and Sundwall, A. (1969): J. Neurochem. 26:695–700.
Schuster, P., Gabriel, E., Kufferle, B. and Karobath, M. (1976): Lancet 7949:37–38.
Sitaram, N., Wyatt, R.J., Dawson, S. and Gillin, J. C. (1976) Science 191:1281–1283.
Snyder, S., Greenberg, D. and Yamamura, H.I. (1974): Arch. Gen. Psychiat. 31:58–61.
Stedman, E. and Stedman, E. (1937): Biochem. J. 31:817–827.
Stille, G., Lavener, M. and Eichenberger, E. (1971): Ed. Pract. Farm. 26:603–625.
Tarsy, D., Leopold, N. and Sax, D.S. (1974): Neurology 24:28–33.
Trabucchi, M., Cheney, D., Racagni, G. and Costa, E. (1974): Nature 249:664–666.
Walker, J.E., Hoehn, M., Sears, E. and Lewis, J. (1973): 1:1512–1513.
Van Putten, T., Mutalipassi, L.R. and Malkin, M.D. (1974): Arch. Gen. Psychiat. 30:102–105.
Wastek, G. J., Stern, L.Z., Johnson, P.C. and Yamamura, H.I. (1976): Life Sci. 19:1033–1039.
Welch, M.J., Markham, C.H. and Jenden, D.J. (1976): J. Neurol. Neurosurg. Psychiat. 39:367–374.
Wray, S.R. (1976): Neuropharmacology 15:269–271.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Schuberth, J. (1978). Central Cholinergic Dysfunctions in Man: Clinical Manifestations and Approaches to Diagnosis and Treatment. In: Jenden, D.J. (eds) Cholinergic Mechanisms and Psychopharmacology. Advances in Behavioral Biology, vol 24. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3096-7_50
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3096-7_50
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3098-1
Online ISBN: 978-1-4684-3096-7
eBook Packages: Springer Book Archive